Discovery of novel ID2 antagonists from pharmacophore-based virtual screening as potential therapeutics for glioma
G. Zhong, Y. Wang, Q. Wang, M. Wu, Y. Liu, S. Sun, Z. Li, J. Hao, P. Dou, B. Lin
This study identifies AK-778-XXMU as a potent ID2 antagonist with potential as a glioma therapeutic through pharmacophore-based virtual screening and experimental validation.
bioRxiv · May 10, 2021Cancer Biology